CLINICAL TRIALS PROFILE FOR ALPHANATE
✉ Email this page to a colleague
All Clinical Trials for ALPHANATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00323856 ↗ | Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A | Active, not recruiting | Grifols Biologicals Inc. | Phase 4 | 2003-01-01 | The purpose of this study is to determine the immunologic and overall safety associated with long-term use of Alphanate in subjects diagnosed with severe hemophilia A (Factor VIII:C less than 0.01 IU/ml), who have been previously treated with plasma-derived Factor VIII products other than Alphanate and who have no history of developing either antibody inhibitors to Factor VIII or nonspecific inhibitors of coagulation. |
| NCT00323856 ↗ | Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A | Active, not recruiting | Grifols Biologicals, LLC | Phase 4 | 2003-01-01 | The purpose of this study is to determine the immunologic and overall safety associated with long-term use of Alphanate in subjects diagnosed with severe hemophilia A (Factor VIII:C less than 0.01 IU/ml), who have been previously treated with plasma-derived Factor VIII products other than Alphanate and who have no history of developing either antibody inhibitors to Factor VIII or nonspecific inhibitors of coagulation. |
| NCT01051076 ↗ | Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) | Completed | Biotest Pharmaceuticals Corporation | N/A | 2009-11-03 | The purpose of this study is to evaluate whether a concentrate containing both FVIII and von Willebrand Factor (VWF) given at a high dose will induce immune tolerance in subjects who have already experienced and failed ITI with VWF-free FVIII concentrates. The treatment on this study is expected to last up to 33 months. |
| NCT01051076 ↗ | Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) | Completed | Charta Fondazione | N/A | 2009-11-03 | The purpose of this study is to evaluate whether a concentrate containing both FVIII and von Willebrand Factor (VWF) given at a high dose will induce immune tolerance in subjects who have already experienced and failed ITI with VWF-free FVIII concentrates. The treatment on this study is expected to last up to 33 months. |
| NCT01051076 ↗ | Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) | Completed | Charta Foundation | N/A | 2009-11-03 | The purpose of this study is to evaluate whether a concentrate containing both FVIII and von Willebrand Factor (VWF) given at a high dose will induce immune tolerance in subjects who have already experienced and failed ITI with VWF-free FVIII concentrates. The treatment on this study is expected to last up to 33 months. |
| NCT01051076 ↗ | Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) | Completed | CSL Behring | N/A | 2009-11-03 | The purpose of this study is to evaluate whether a concentrate containing both FVIII and von Willebrand Factor (VWF) given at a high dose will induce immune tolerance in subjects who have already experienced and failed ITI with VWF-free FVIII concentrates. The treatment on this study is expected to last up to 33 months. |
| NCT01051076 ↗ | Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) | Completed | Grifols Biologicals Inc. | N/A | 2009-11-03 | The purpose of this study is to evaluate whether a concentrate containing both FVIII and von Willebrand Factor (VWF) given at a high dose will induce immune tolerance in subjects who have already experienced and failed ITI with VWF-free FVIII concentrates. The treatment on this study is expected to last up to 33 months. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ALPHANATE
Condition Name
Clinical Trial Locations for ALPHANATE
Trials by Country
Clinical Trial Progress for ALPHANATE
Clinical Trial Phase
Clinical Trial Sponsors for ALPHANATE
Sponsor Name
